Unichem Lab receives US FDA nod for Carbamazepine drugs

Unichem Lab receives US FDA nod for Carbamazepine drugs

by admin- Tuesday, August 23rd, 2022 03:33:42 PM

Unichem Laboratories obtained ANDA approval for its Carbamazepine Tablets USP, two hundred mg from the USA Food and Drug Administration (USFDA) to marketplace a familiar version of TEGRETOL (Carbamazepine) Tablet, 2 hundred mg of Novartis Pharmaceuticals Corp.

Carbamazepine Tablets are indicated to be used as an anticonvulsant drug and in the remedy of the ache related to proper trigeminal neuralgia. The product might be commercialized from Unichem’s Goa Plant.

News Updates